Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Ahmet Cingöz

8PUBLICATIONS
30CO-AUTHORS
Gene and molecular therapyPredictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

Sort by Publication Date:
|Apr 29, 2026
Genetically engineered human cell-based microrobots for selective cancer cell death.

|Dec 04, 2025
Distinct transcription factor interactions drive HOXB13 activity in different stages of prostate cancer.

Betul Ersoy-Fazlioglu, Shreyas Lingadahalli, Umut Berkay Altintas

|Jun 29, 2025
Chromatin-focused genetic and chemical screens identify BRPF1 as a targetable vulnerability in Taxol-resistant triple-negative breast cancer.

Ozlem Yedier-Bayram, Ahmet Cingöz, Ebru Yilmaz

|Jul 23, 2024
Editorial Expression of Concern: Generation of TRAIL-resistant cell line models reveals distinct adaptive mechanisms for acquired resistance and re-sensitization.

Ahmet Cingöz, Ezgi Ozyerli-Goknar, Tunc Morova

|Mar 26, 2021
Generation of TRAIL-resistant cell line models reveals distinct adaptive mechanisms for acquired resistance and re-sensitization.

Ahmet Cingöz, Ezgi Ozyerli-Goknar, Tunc Morova

|Jul 28, 2020
TRAIL-conjugated silver nanoparticles sensitize glioblastoma cells to TRAIL by regulating CHK1 in the DNA repair pathway.

Ilknur Sur-Erdem, Kerem Muslu, Nareg Pınarbası

Pageof 2

Frequent Collaborators

8 joint publications

Tugba Bagcı-Önder

2 joint publications

Tamer T Onder

2 joint publications

Khalid Shah

2 joint publications

Myvizhi Esai Selvan

2 joint publications

Zeynep Hülya Gümüş

2 joint publications

Deepak Bhere

1 joint publications

James Dunford

1 joint publications

Udo Oppermann

1 joint publications

Akane Kawamura

1 joint publications

Kerem Muslu

Frequent Collaborators

8 joint publications

Tugba Bagcı-Önder

2 joint publications

Tamer T Onder

2 joint publications

Khalid Shah

2 joint publications

Myvizhi Esai Selvan

Top Related Videos

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
07:23

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Published on : May 30, 2025

1.3K
<em>HOX</em> Loci Focused CRISPR/sgRNA Library Screening Identifying Critical CTCF Boundaries
10:10

<em>HOX</em> Loci Focused CRISPR/sgRNA Library Screening Identifying Critical CTCF Boundaries

Published on : Mar 31, 2019

8.7K
Functional Assessment of <em>BRCA1</em> variants using CRISPR-Mediated Base Editors
09:22

Functional Assessment of <em>BRCA1</em> variants using CRISPR-Mediated Base Editors

Published on : Feb 28, 2021

5.6K
See more related videos

Top Related Videos

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
07:23

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Published on : May 30, 2025

1.3K
<em>HOX</em> Loci Focused CRISPR/sgRNA Library Screening Identifying Critical CTCF Boundaries
10:10

<em>HOX</em> Loci Focused CRISPR/sgRNA Library Screening Identifying Critical CTCF Boundaries

Published on : Mar 31, 2019

8.7K
Functional Assessment of <em>BRCA1</em> variants using CRISPR-Mediated Base Editors
09:22

Functional Assessment of <em>BRCA1</em> variants using CRISPR-Mediated Base Editors

Published on : Feb 28, 2021

5.6K
See more related videos